Our total funding + revenues are much higher. You missed the part about Khosla Ventures, DARPA, and Fortune 500 contracts, and that we are already profitable :). Biology, especially when done through software, is a very profitable domain.
Our total funding + revenues are much higher. You missed the part about Khosla Ventures, DARPA, and Fortune 500 contracts, and that we are already profitable :). Biology, especially when done through software, is a very profitable domain.